Skip Navigation


Carcinogenesis Advance Access originally published online on January 12, 2006
Carcinogenesis 2006 27(7):1386-1390; doi:10.1093/carcin/bgi332
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/7/1386    most recent
bgi332v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Manenti, G.
Right arrow Articles by Dragani, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manenti, G.
Right arrow Articles by Dragani, T. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients

Giacomo Manenti, Federica Galbiati, Angela Pettinicchio, Monica Spinola, Silvia Piconese, Vera Piera Leoni, Barbara Conti 1, Fernando Ravagnani, Matteo Incarbone 2, Ugo Pastorino 1 and Tommaso A. Dragani *

Department of Experimental Oncology and Laboratories and 1 Department of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy and 2 Department of Thoracic Surgery, Istituto Clinico Humanitas (ICH), Rozzano, Italy

* To whom correspondence should be addressed at: Department of Experimental Oncology, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milan, Italy. Tel: +39 0223902642, Fax: +39 0223903237; Email: tommaso.dragani{at}istitutotumori.mi.it

Mouse Lrmp and Casc1 genes are candidates for the pulmonary adenoma susceptibility 1 (Pas1) locus, the major determinant of strain variation in lung tumor susceptibility. These genes contain coding and non-coding single nucleotide polymorphisms (SNPs) strongly associated with lung tumor risk in mice. Analysis of LRMP and CASC1 gene SNPs in 361 lung adenocarcinoma (ADCA) patients and 327 healthy controls revealed common SNPs in LRMP (V141L and S197C) and CASC1 (R33S and three intronic variations), and none showed a significant association with lung ADCA risk. However, in the time-dependent Cox regression model, after adjustment for age, gender, smoking history and clinical stage, the carrier status of the Leu variation (V141L) of the LRMP gene was associated with higher mortality in patients with age at tumor onset ≤ 65 years [hazard ratio (HR) 2.3; 95% CI 1.4–3.7; P = 0.001]. These findings suggest that the LRMP V141L polymorphism can predict survival in lung ADCA and that the role of LRMP and CASC1 in human lung cancer risk may differ from that in mice.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
T. Kohno, H. Kunitoh, K. Suzuki, S. Yamamoto, A. Kuchiba, Y. Matsuno, N. Yanagitani, and J. Yokota
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias
Carcinogenesis, May 1, 2008; 29(5): 957 - 963.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.